The novel predictor of metabolic risk in patients with polycystic ovary syndrome: could it be the visceral adiposity index?

Apaydin, M.; Kazan, E. D.; Beysel, S.; Sari, A.; Ozgul, E.; Cengiz, H.; Demirci, T.; Yilmazer, M.

DSpace Home
→
Araştırma Çıktıları / Research Outputs
→
WOS İndeksli Yayınlar Koleksiyonu / WOS Indexed Publications Collection
→
View Item

dc.contributor.authors	Apaydin, M.; Kazan, E. D.; Beysel, S.; Sari, A.; Ozgul, E.; Cengiz, H.; Demirci, T.; Yilmazer, M.
dc.date.accessioned	2022-12-20T13:24:59Z
dc.date.available	2022-12-20T13:24:59Z
dc.date.issued	2022
dc.identifier.issn	1128-3602
dc.identifier.uri	https://hdl.handle.net/20.500.12619/99138
dc.description	Bu yayının lisans anlaşması koşulları tam metin açık erişimine izin vermemektedir.
dc.description.abstract	- OBJECTIVE: Polycystic ovary syndrome (PCOS) is the most common endo-crinological disorder in women of reproduc-tive age, often accompanied by high androgen levels, irregular menstrual cycles and polycys-tic ovaries. In addition, patients with PCOS al-so
dc.language	English
dc.language.iso	eng
dc.subject	Pharmacology & Pharmacy
dc.subject	Cardiometabolic risk
dc.subject	Insulin resistance
dc.subject	Polycystic ovary syndrome
dc.subject	VAI
dc.title	The novel predictor of metabolic risk in patients with polycystic ovary syndrome: could it be the visceral adiposity index?
dc.identifier.volume	26
dc.identifier.startpage	7182
dc.identifier.endpage	7187
dc.relation.journal	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
dc.identifier.issue	19
dc.contributor.author	Apaydin, M.
dc.contributor.author	Kazan, E. D.
dc.contributor.author	Beysel, S.
dc.contributor.author	Sari, A.
dc.contributor.author	Ozgul, E.
dc.contributor.author	Cengiz, H.
dc.contributor.author	Demirci, T.
dc.contributor.author	Yilmazer, M.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı